You are here: Industry Insights > acquisition

News List

Centinel Spine Completes Acquisition of prodisc Assets prnasia
December 25, 2017
Centinel Spine, LLC (CS) is pleased to announce the acquisition of the worldwide assets of the prodisc® Total Disc Replacement portfolio from DePuy Synthes Products, Inc.
JSR Life Sciences Snaps Up CRO in $400M Deal biospace
December 21, 2017
The parent company of JSR Life Sciences snapped up contract research organization Crown Bioscience International for $400 million, the company announced this morning.
Malaysia based Chemopharm acquired by Everstone Group biospectrumasia
November 27, 2017
Singapore-based Cure Capital acted as a co-investor in the transaction.
Shanghai Pharma buys drug distribution unit of US-based Cardinal Health biospectrumasia
November 22, 2017
Shanghai Pharma and Cardinal Health have reached a strategic cooperation agreement to explore business development in the U.S., as well as collaborate in developing the global market for medical equipment and service innovation.
Tucson Startup Revolutionary Medical Devices bought by Chicago firm biospectrumasia
November 07, 2017
Vyaire, formerly known as CareFusion, has been assembling a line of respiratory products through acquisitions.
Factory CRO announces acquisition of Milestone Research Organization pharmaasia
November 06, 2017
Global contract research organisation Factory CRO expands its operations to North America with the acquisition of San Diego-based Milestone Research.
China’s Fosun Pharma takeover of an Indian pharma giant biospectrumasia
October 27, 2017
The deal will help the Chinese company make inroads into India, gain access to US injectable drug market where Gland has a firm hold and bolster its product portfolio
China Biologic plans acquisition of TianXinFu biospectrumasia
October 16, 2017
China Biologic will issue 5,521,000 ordinary shares to PW Medtech.
Thermo Fisher Scientific Completes Acquisition of Patheon pharmaceutical-technology
August 31, 2017
Thermo Fisher Scientific has completed its acquisition of Patheon, a contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion.
Evotec buys Aptuit for nearly $300m pharmaceutical-technology
August 18, 2017
German company Evotec has completed the acquisition of Aptuit for a total consideration of approximately $300m to support its long-term strategy to be the industry partner of choice for external drug discovery and development innovation.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page